Loading clinical trials...
Loading clinical trials...
Study to Evaluate the Pharmacokinetic, Safety, and Efficacy of TAF in HBV-Infected Pregnant Women
Conditions
Interventions
Tenofovir Alafenamide Tablets
Locations
1
China
Hangzhou First People's Hospital
Hangzhou, Zhejiang, China
Start Date
May 6, 2021
Primary Completion Date
December 30, 2025
Completion Date
December 30, 2025
Last Updated
September 8, 2025
NCT07417553
NCT02932150
NCT06671093
NCT06885710
NCT06906016
NCT06263959
Lead Sponsor
First People's Hospital of Hangzhou
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions